ThalesNano announces the launch of X-Cube Flash™, its next generation high temperature and pressure continuous process reactor
News Apr 03, 2008
ThalesNano Inc. has announced the launch of the latest in its Cube™ flow reactor series, the X-Cube Flash™. This novel product is validated with several important chemistry applications. The X-Cube Flash™ will be officially unveiled in the US, at the 235th National Meeting of the of the American Chemical Society, held April 6-10 in New Orleans, LA, and in Europe at the Advances in Synthetic Chemistry conference in Frankfurt held on April 8 and 9.
The X-Cube Flash™ is designed to carry out homogenous reactions in continuous flow mode at high pressure and temperature, operating safely up to 200 bar and 350°C. This enables chemists to significantly expand the parameter space they can utilize within a regular laboratory setting. The system is also applicable for doing chemistry under supercritical conditions.
Dr. Laszlo Urge, CEO of ThalesNano commented: “We call our latest X-Cube™ reactor the “Flash”, because most reactions proceed in seconds or minutes instead of hours. The X-Cube Flash™ fulfills the need of our customers for safe high pressure and temperature homogenous reactions. In addition it can be used to scale up microwave assisted reactions quickly with little method development. Our experience shows that the system can be utilized to reduce hazardous waste production in many chemical processes. In certain chemical transformations, it also eliminates the need for using expensive and toxic heavy metal catalysts fulfilling the requirements of Green Chemistry. The pharmaceutical industry is increasingly adopting continuous processes and this system can provide a ready state of the art solution for testing and optimizing chemistries for continuous process applications on a larger scale later. The increase in productivity and chemical efficiency can result in significant cost and time savings for those R&D organizations who adopt this technology.”
“This product will be a complementary addition to our existing X-Cube™ technology. With its launch we have further diversified our continuous process technology portfolio giving ThalesNano the widest product range available in bench top flow chemistry and continuous process technology. The company is executing a complex strategy designed to provide integrated continuous flow solutions from discovery to full scale production which could help solve some of the key bottlenecks in the pharmaceutical, biotechnology and chemical industries” stated Dr. Ferenc Darvas, President and Chairman at ThalesNano.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019